Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 134
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Food Funct ; 12(7): 3233-3245, 2021 Apr 07.
Artigo em Inglês | MEDLINE | ID: mdl-33877247

RESUMO

This research was aimed to assess the potential of Glechoma hederacea, Hyssopus officinalis, Lavandula angustifolia, Leonurus cardiaca, Marrubium vulgare and Sideritis scardica (Lamiaceae) methanolic, ethanolic and aqueous extracts against the damaging effects of oxidative stress using different experimental models. The chemical characterization was done spectrophotometrically by quantifying total phenolics, phenolic acids, flavonoids and flavonols in the extracts, as well as by employing HPLC-DAD technique. Moreover, DPPH assay was used to assess the extracts' radical scavenging potential. Genoprotective properties of the extracts were evaluated using plasmid pUC19 Escherichia coli XL1-Blue, whereas their antigenotoxic potential was determined using Salmonella typhimurium TA1535/pSK1002 and normal human lung fibroblasts. All of the extracts showed antioxidant activity in DPPH assay. Furthermore, the results have shown that aqueous extracts provided the best protection for plasmid DNA, while alcoholic extracts most effectively contributed to the preservation of prokaryotic DNA. Additionally, each of the tested samples significantly protected the eukaryotic cells against genomic damages. Finally, despite not showing exceptional results in DPPH assay, S. scardica extracts are regarded as the most favorable in maintaining the integrity of DNA, which might be due to high quantities of phenolics such as quercetin (up to 17.95 mg g-1), naringin (up to 5.07 mg g-1) and luteolin-7-O-glucoside (up to 3.54 mg g-1). Overall, this comprehensive concept highlights the ability of these Lamiaceae species to safeguard the DNA from reactive oxygen species, to curtail the inflicted damage and also improve the efficiency of the DNA repair mechanisms, while emphasizing the importance of polyphenols as their active principles.


Assuntos
Antimutagênicos/farmacologia , Antioxidantes/farmacologia , Lamiaceae/química , Extratos Vegetais/química , Dano ao DNA/efeitos dos fármacos , Reparo do DNA , Fibroblastos/efeitos dos fármacos , Flavonoides/análise , Humanos , Testes de Mutagenicidade , Estresse Oxidativo/efeitos dos fármacos , Polifenóis/análise , Salmonella typhimurium/metabolismo
2.
Metallomics ; 12(12): 2021-2031, 2020 12 23.
Artigo em Inglês | MEDLINE | ID: mdl-33165471

RESUMO

Cobalt is an essential element for living systems, which, however, make very limited use of this metal, using it mainly in cobalamin-containing enzymes. The reduced use of cobalt compared to other transition metals is generally attributed to the potential toxicity of this element. In this work, we demonstrate that cobalt not only does not have an obvious toxic effect on Salmonella Typhimurium, but that it can efficiently compensate for zinc deficiency in a znuABC deleted strain. In fact, cobalt, but not cobalamin supplementation, rescued all major phenotypic defects of the znuABC strain, including the reduced ability to grow and swim in zinc-deficient media and the high susceptibility to hydrogen peroxide stress. Growth in a cobalt-supplemented defined medium led to the accumulation of large amounts of cobalt both in the wild type and in the znuABC strain. These data suggest that atoms of cobalt may be incorporated in bacterial proteins in place of zinc, ensuring their functionality. In support of this hypothesis we have shown that, in vivo, cobalt can accumulate in ribosomes and replace zinc in a periplasmic Cu,Zn superoxide dismutase (SodCII). Finally, we provide evidence of the ability of cobalt to modulate the intracellular concentration of zinc-regulated proteins (ZnuA, ZinT, and SodCII). Although some observations suggest that in some proteins the replacement of zinc with cobalt can lead to subtle structural changes, the data reported in this study indicate that Salmonella has the ability to use cobalt instead of zinc, without evident harmful effects for cell physiology.


Assuntos
Cobalto/metabolismo , Salmonella typhimurium/metabolismo , Zinco/metabolismo , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Deleção de Genes , Regulação Bacteriana da Expressão Gênica , Humanos , Infecções por Salmonella/microbiologia , Salmonella typhimurium/genética , Salmonella typhimurium/crescimento & desenvolvimento
3.
Drug Discov Ther ; 14(5): 243-248, 2020 Nov 04.
Artigo em Inglês | MEDLINE | ID: mdl-33116038

RESUMO

The bark of Cinnamomum bejolghota (Buch.-Ham.) Sweet (C. bejolghota) is widely used as medicine to treat bacterial diarrhea in Myanmar. We previously reported that the bark extract of C. bejolghota significantly inhibited secretion effector proteins of the type three secretion system (T3SS) in Salmonella. This study is designed to investigate the anti-virulence potential of the C. bejolghota bark extract against Salmonella Typhimuriumin in in vivo and in vitro experiments. The results suggested that the polar fraction Fr.M1 inhibited the secretion of effector proteins SipA, SipB, SipC and SipD without affecting bacteria growth and the translocation of SipC into MDA-MB-231 cells. In addition, Fr.M1 alleviated inflammatory symptoms of mice in Salmonella-infected mouse model. Overall, the results provide evidence for medicinal usage of C. bejolghota bark to treat diarrhea in Myanmar.


Assuntos
Cinnamomum/química , Plantas Medicinais/química , Salmonella typhimurium/efeitos dos fármacos , Sistemas de Secreção Tipo III/efeitos dos fármacos , Animais , Anti-Infecciosos/farmacologia , Antivirais/farmacologia , Cinnamomum/efeitos adversos , Cinnamomum/metabolismo , Disenteria/tratamento farmacológico , Feminino , Humanos , Masculino , Camundongos , Modelos Animais , Mianmar/epidemiologia , Plantas Medicinais/efeitos adversos , Plantas Medicinais/metabolismo , Infecções por Salmonella/prevenção & controle , Salmonella typhimurium/metabolismo
4.
PLoS One ; 15(6): e0232831, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32497096

RESUMO

The burden of enteric pathogens in poultry is growing after the ban of antibiotic use in animal production. Organic acids gained attention as a possible alternative to antibiotics due to their antimicrobial activities, improved nutrient metabolism and performance. The current study was conducted to evaluate the effectiveness of organic acid blend on broilers cecal microbiota, histomorphometric measurements, and short-chain fatty acid production in Salmonella enterica serovar Typhimurium challenge model. Birds were divided into four treatments, including a negative control, positive control challenged with S. Typhimurium, group supplemented with an organic acid blend, and birds supplemented with organic acid blend and Salmonella challenged. Results illustrate significant differences in feed conversion ratios and production efficiency factor between treatment groups, however, the influence of organic acid supplement was marginal. Organic acid blend significantly increased cecal acetic and butyric acids concentrations when compared to unsupplemented groups and resulted in minor alterations of intestinal bacterial communities.


Assuntos
Acetatos/metabolismo , Ração Animal , Butiratos/metabolismo , Galinhas/microbiologia , Suplementos Nutricionais , Ácidos Graxos/farmacologia , Microbioma Gastrointestinal/efeitos dos fármacos , Doenças das Aves Domésticas/terapia , Salmonelose Animal/terapia , Salmonella typhimurium/efeitos dos fármacos , Animais , Ceco/microbiologia , Galinhas/metabolismo , Ácidos Graxos/administração & dosagem , Ácidos Graxos Voláteis/administração & dosagem , Ácidos Graxos Voláteis/farmacologia , Íleo/metabolismo , Íleo/ultraestrutura , Mananas/administração & dosagem , Microvilosidades/ultraestrutura , Doenças das Aves Domésticas/microbiologia , Doenças das Aves Domésticas/prevenção & controle , Distribuição Aleatória , Salmonelose Animal/microbiologia , Salmonelose Animal/prevenção & controle , Salmonella typhimurium/isolamento & purificação , Salmonella typhimurium/metabolismo
5.
Food Sci Technol Int ; 26(2): 151-159, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-31544526

RESUMO

Resistant bacteria to antimicrobials are increasingly emerging in medical, food industry and livestock environments. The present research work assesses the capability of Salmonella enterica var Typhimurium to become adapted under the exposure to a natural cauliflower antimicrobial by-product infusion in consecutive repeated exposure cycles. Caenorhabditis elegans was proposed as in vivo host-test organism to compare possible changes in the virulent pattern of the different rounds treated S. enterica var Typhimurium and untreated bacterial cells. According to the obtained results, S. enterica var Typhimurium was able to generate resistance against a repeated exposure to cauliflower by-product infusion 5% (w/v), increasing the resistance with the number of exposed repetitions. Meanwhile, at the first exposure, cauliflower by-product infusion was effective in reducing S. enterica var Typhimurium (≈1 log10 cycle), and S. enterica var Typhimurium became resistant to this natural antimicrobial after the second and third treatment-round and was able to grow (≈1 log10 cycle). In spite of the increased resistance observed for repeatedly treated bacteria, the present study reveals no changes on C. elegans infection effects between resistant and untreated S. enterica var Typhimurium, according to phenotypic parameters evaluation (lifespan duration and egg-laying).


Assuntos
Anti-Infecciosos/farmacologia , Brassica/química , Caenorhabditis elegans/microbiologia , Farmacorresistência Bacteriana Múltipla , Extratos Vegetais/farmacologia , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/isolamento & purificação , Animais , Caenorhabditis elegans/metabolismo , Interações Hospedeiro-Patógeno/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Extratos Vegetais/análise , Salmonella typhimurium/metabolismo
6.
Infect Immun ; 88(1)2019 12 17.
Artigo em Inglês | MEDLINE | ID: mdl-31611277

RESUMO

To survive and replicate during infection, pathogens utilize different carbon and energy sources depending on the nutritional landscape of their host microenvironment. Salmonella enterica serovar Typhimurium is an intracellular bacterial pathogen that occupies diverse cellular niches. While it is clear that Salmonella Typhimurium requires access to glucose during systemic infection, data on the need for lipid metabolism are mixed. We report that Salmonella Typhimurium strains lacking lipid metabolism genes were defective for systemic infection of mice. Bacterial lipid import, ß-oxidation, and glyoxylate shunt genes were required for tissue colonization upon oral or intraperitoneal inoculation. In cultured macrophages, lipid import and ß-oxidation genes were required for bacterial replication and/or survival only when the cell culture medium was supplemented with nonessential amino acids. Removal of glucose from tissue culture medium further enhanced these phenotypes and, in addition, conferred a requirement for glyoxylate shunt genes. We also observed that Salmonella Typhimurium needs lipid metabolism genes in proinflammatory but not anti-inflammatory macrophages. These results suggest that during systemic infection, the Salmonella Typhimurium that relies upon host lipids to replicate is within proinflammatory macrophages that have access to amino acids but not glucose. An improved understanding of the host microenvironments in which pathogens have specific metabolic requirements may facilitate the development of targeted approaches to treatment.


Assuntos
Metabolismo dos Lipídeos , Macrófagos/microbiologia , Redes e Vias Metabólicas/genética , Salmonella typhimurium/crescimento & desenvolvimento , Salmonella typhimurium/metabolismo , Aminoácidos/metabolismo , Animais , Glucose/metabolismo , Camundongos , Viabilidade Microbiana , Salmonelose Animal/microbiologia , Salmonelose Animal/patologia , Salmonella typhimurium/genética
7.
Food Res Int ; 123: 1-10, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31284956

RESUMO

Multivariate data analysis feasibility for the evaluation of Brazilian stingless bee honey (SBH) by pollen spectrum, bioactive compounds content, physicochemical, antioxidant and antimicrobial analysis was investigated. Levels of total and individual phenolics content were analyzed by HPLC-PDA. The antioxidant capacity was performed by 2,2-diphenyl-1-picrylhydrazyl free radical (DPPH), oxygen radical absorption capacity (ORAC) and ferric reducing antioxidant power (FRAP) assays. The total phenolic compounds from the thirty-two SBH was positively correlated with the antioxidant capacity. Bioactive compounds such as p-coumaric acid, quercetin, and hesperetin were identified in all the samples. Brazilian SBH shows more effective antibacterial activity against Gram-negative bacteria (E. coli and S. Typhimurium) compared to Gram-positive ones. Results also revealed that SBH could reach up to 45% higher antioxidant and biological activities than the traditional Apis mellifera honey. Chemometrics shows that chemical and biological properties of SBH have a strong relationship with the pollen botanical origin. Principal component analysis (PCA) grouped the honey into three categories with predominant pollen from Verbenaceae, Asteraceae and Sapindaceae families, confirming that SBH belonging to the same floral origin present similar characteristics.


Assuntos
Abelhas/classificação , Mel/análise , Pólen/química , Animais , Antibacterianos/análise , Antibacterianos/farmacologia , Antioxidantes/análise , Abelhas/metabolismo , Compostos de Bifenilo/análise , Brasil , Fenômenos Químicos , Cromatografia Líquida de Alta Pressão , Escherichia coli/efeitos dos fármacos , Escherichia coli/metabolismo , Radicais Livres/análise , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Negativas/metabolismo , Bactérias Gram-Positivas/efeitos dos fármacos , Bactérias Gram-Positivas/metabolismo , Indicadores e Reagentes/análise , Análise Multivariada , Fenóis/análise , Picratos/análise , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/metabolismo
8.
Biomaterials ; 214: 119226, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31174068

RESUMO

Bacteria-driven drug-delivery systems have attracted great attention for their enhanced therapeutic specificity and efficacy in cancer treatment. YB1, a particularly attractive genetically modified safe Salmonella Typhimurium strain, is known to penetrate hypoxic tumor cores with its self-driven properties while remarkably avoiding damage to normal tissues. Herein, nanophotosensitizers (indocyanine green (ICG)-loaded nanoparticles, INPs) were covalently attached to the surface of YB1 with amide bonds to develop a biotic/abiotic cross-linked system (YB1-INPs) for tumor precision therapy. YB1 microswimmer retained its viability after efficiently linking with INPs. This YB1-INPs treatment strategy demonstrated specific hypoxia targeting to solid tumors, perfect photothermal conversion, and efficient fluorescence (FL) imaging properties. Benefited from the combined contribution of tumor tissue destruction and the bacteria-attracting nutrients generation after photothermal treatment, the bioaccumulation of YB1-INPs was significantly improved 14-fold compared to no photothermal intervention. Furthermore, YB1-INPs pervaded throughout the large solid tumor (≥500 mm3). Under near-infrared (NIR) laser irradiation, YB1-INPs exhibited a dependable and highly efficient photothermal killing ability for eradicating the large solid tumor without relapse. This strategy of bacteria-driven hypoxia-targeting delivery has a great value for large solid tumors therapy with low toxicity and high efficiency.


Assuntos
Salmonella/fisiologia , Neoplasias da Bexiga Urinária/terapia , Animais , Bioacumulação , Feminino , Imunofluorescência , Hipertermia Induzida/métodos , Imuno-Histoquímica , Verde de Indocianina/química , Camundongos , Camundongos Endogâmicos C57BL , Viabilidade Microbiana , Nanopartículas/química , Fototerapia/métodos , Salmonella/metabolismo , Salmonella typhimurium/metabolismo , Salmonella typhimurium/fisiologia , Temperatura , Neoplasias da Bexiga Urinária/microbiologia
9.
Chem Commun (Camb) ; 55(6): 763-766, 2019 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-30480264

RESUMO

Specifically designed, antisense oligonucleotides are promising candidates for antibacterial drugs. They suppress the correct expression of bacterial genes by complementary binding to essential sequences of bacterial DNA or RNA. The main obstacle in fully utilizing their potential as therapeutic agents comes from the fact that bacteria do not uptake oligonucleotides from their environment. Herein, we report that vitamin B12 can transport oligonucleotides into Escherichia coli and Salmonella typhimurium cells. 5'-Aminocobalamin with an alkyne linker and azide-modified oligonucleotides enabled the synthesis of vitamin B12-2'OMeRNA conjugates using an efficient "click" methodology. Inhibition of protein expression in E. coli and S. Typhimurium cells indicates an unprecedented transport of 2'OMeRNA oligomers into bacterial cells via the vitamin B12 delivery pathway.


Assuntos
Escherichia coli/metabolismo , Oligonucleotídeos Antissenso/química , Salmonella typhimurium/metabolismo , Vitamina B 12/química , Alcinos/química , Azidas/química , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Catálise , Cobre/química , Escherichia coli/genética , Oligonucleotídeos Antissenso/metabolismo , RNA/antagonistas & inibidores , RNA/genética , RNA/metabolismo , Salmonella typhimurium/genética
10.
J Am Chem Soc ; 138(7): 2209-18, 2016 Feb 24.
Artigo em Inglês | MEDLINE | ID: mdl-26847396

RESUMO

Traditional Chinese Medicines (TCMs) have been historically used to treat bacterial infections. However, the molecules responsible for these anti-infective properties and their potential mechanisms of action have remained elusive. Using a high-throughput assay for type III protein secretion in Salmonella enterica serovar Typhimurium, we discovered that several TCMs can attenuate this key virulence pathway without affecting bacterial growth. Among the active TCMs, we discovered that baicalein, a specific flavonoid from Scutellaria baicalensis, targets S. Typhimurium pathogenicity island-1 (SPI-1) type III secretion system (T3SS) effectors and translocases to inhibit bacterial invasion of epithelial cells. Structurally related flavonoids present in other TCMs, such as quercetin, also inactivated the SPI-1 T3SS and attenuated S. Typhimurium invasion. Our results demonstrate that specific plant metabolites from TCMs can directly interfere with key bacterial virulence pathways and reveal a previously unappreciated mechanism of action for anti-infective medicinal plants.


Assuntos
Antibacterianos/farmacologia , Medicamentos de Ervas Chinesas/farmacologia , Flavonoides/farmacologia , Plantas Medicinais/química , Salmonella typhimurium/efeitos dos fármacos , Sistemas de Secreção Tipo III/metabolismo , Antibacterianos/química , Antibacterianos/isolamento & purificação , Relação Dose-Resposta a Droga , Medicamentos de Ervas Chinesas/química , Medicamentos de Ervas Chinesas/isolamento & purificação , Flavonoides/química , Flavonoides/isolamento & purificação , Ensaios de Triagem em Larga Escala , Testes de Sensibilidade Microbiana , Estrutura Molecular , Salmonella typhimurium/metabolismo , Relação Estrutura-Atividade , Especificidade por Substrato
11.
Food Chem ; 197(Pt A): 648-57, 2016 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-26616999

RESUMO

Elderberry (EDB) Sambucus nigra L. is one of the oldest medicinal plants which is useful for therapeutic and nutritional purposes due to a large amount of biologically active constituents, including compounds with a high antioxidant capacity. The present study focused on the antioxidant potential of the colon-available EDB fruit extract, derived from the artificial gastrointestinal tract, with regard to human colonic mucosa cells cultured in vitro. Despite the significant loss of EDB bioactive compounds due to the digestion process, the colon-digested extract was able to reduce the excessive intracellular ROS production (22%) and oxidative DNA damage (46%) in the colon cells at a dose of 1 mg of freeze-dried EDB powder/ml. Moreover, the colon-digested EDB extract inhibited oxidant-induced mutagenicity (26%) in the Salmonella typhimurium TA102 strain, as determined by the Ames test. In conclusion, the current in vitro study confirmed that the fruits of S. nigra are capable of protecting colonic cells against the detrimental effects of oxidative stress.


Assuntos
Colo/citologia , Frutas/química , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/farmacologia , Sambucus nigra/química , Antioxidantes/química , Antioxidantes/farmacologia , Linhagem Celular , Colo/efeitos dos fármacos , Colo/metabolismo , Dano ao DNA/efeitos dos fármacos , Humanos , Peróxido de Hidrogênio/toxicidade , Mucosa Intestinal/efeitos dos fármacos , Mutagênicos/toxicidade , Extratos Vegetais/análise , Espécies Reativas de Oxigênio/metabolismo , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/metabolismo
12.
Autophagy ; 11(10): 1775-89, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26506893

RESUMO

The autophagy receptor CALCOCO2/NDP52 functions as a bridging adaptor and plays an essential role in the selective autophagic degradation of invading pathogens by specifically recognizing ubiquitin-coated intracellular pathogens and subsequently targeting them to the autophagic machinery; thereby it is required for innate immune defense against a range of infectious pathogens in mammals. However, the mechanistic basis underlying CALCOCO2-mediated specific recognition of ubiqutinated pathogens is still unknown. Here, using biochemical and structural analyses, we demonstrated that the cargo-binding region of CALCOCO2 contains a dynamic unconventional zinc finger as well as a C2H2-type zinc-finger, and only the C2H2-type zinc finger specifically recognizes mono-ubiquitin or poly-ubiquitin chains. In addition to elucidating the specific ubiquitin recognition mechanism of CALCOCO2, the structure of the CALCOCO2 C2H2-type zinc finger in complex with mono-ubiquitin also uncovers a unique zinc finger-binding mode for ubiquitin. Our findings provide mechanistic insight into how CALCOCO2 targets ubiquitin-decorated pathogens for autophagic degradations.


Assuntos
Autofagia/fisiologia , Proteínas de Transporte/metabolismo , Proteínas Nucleares/metabolismo , Infecções por Salmonella/metabolismo , Salmonella typhimurium/isolamento & purificação , Ubiquitina/metabolismo , Citoplasma/metabolismo , Células HeLa , Humanos , Salmonella typhimurium/metabolismo
13.
Oncotarget ; 6(31): 31335-43, 2015 Oct 13.
Artigo em Inglês | MEDLINE | ID: mdl-26431498

RESUMO

Bone metastasis is a frequent occurrence in prostate cancer patients and often is lethal. Zoledronic acid (ZOL) is often used for bone metastasis with limited efficacy. More effective models and treatment methods are required to improve the outcome of prostate cancer patients. In the present study, the effects of tumor-targeting Salmonella typhimurium A1-R were analyzed in vitro and in vivo on prostate cancer cells and experimental bone metastasis. Both ZOL and S. typhimurium A1-R inhibited the growth of PC-3 cells expressing red fluorescent protien in vitro. To investigate the efficacy of S. typhimurium A1-R on prostate cancer experimental bone metastasis, we established models of both early and advanced stage bone metastasis. The mice were treated with ZOL, S. typhimurium A1-R, and combination therapy of both ZOL and S. typhimurium A1-R. ZOL and S. typhimurium A1-R inhibited the growth of solitary bone metastases. S. typhimurium A1-R treatment significantly decreased bone metastasis and delayed the appearance of PC-3 bone metastases of multiple mouse models. Additionally, S. typhimurium A1-R treatment significantly improved the overall survival of the mice with multiple bone metastases. The results of the present study indicate that S. typhimurium A1-R is useful to prevent and inhibit prostate cancer bone metastasis and has potential for future clinical use in the adjuvant setting.


Assuntos
Terapia Biológica , Neoplasias Ósseas/terapia , Difosfonatos/uso terapêutico , Imidazóis/uso terapêutico , Neoplasias da Próstata/terapia , Salmonelose Animal , Salmonella typhimurium/crescimento & desenvolvimento , Animais , Conservadores da Densidade Óssea/uso terapêutico , Neoplasias Ósseas/microbiologia , Neoplasias Ósseas/secundário , Terapia Combinada , Proteínas de Fluorescência Verde/metabolismo , Humanos , Masculino , Camundongos , Camundongos Nus , Neoplasias da Próstata/microbiologia , Neoplasias da Próstata/patologia , Salmonella typhimurium/metabolismo , Salmonella typhimurium/patogenicidade , Células Tumorais Cultivadas , Ensaios Antitumorais Modelo de Xenoenxerto , Ácido Zoledrônico
14.
Oncotarget ; 6(39): 41856-62, 2015 Dec 08.
Artigo em Inglês | MEDLINE | ID: mdl-26497690

RESUMO

Colon cancer liver metastasis is often the lethal aspect of this disease. Well-isolated metastases are candidates for surgical resection, but recurrence is common. Better adjuvant treatment is therefore needed to reduce or prevent recurrence. In the present study, HT-29 human colon cancer cells expressing red fluorescent protein (RFP) were used to establish liver metastases in nude mice. Mice with a single liver metastasis were randomized into bright-light surgery (BLS) or the combination of BLS and adjuvant treatment with tumor-targeting S. typhimurium A1-R. Residual tumor fluorescence after BLS was clearly visualized at high magnification by fluorescence imaging. Adjuvant treatment with S. typhimurium A1-R was highly effective to increase survival and disease-free survival after BLS of liver metastasis. The results suggest the future clinical potential of adjuvant S. typhimurium A1-R treatment after liver metastasis resection.


Assuntos
Terapia Biológica/métodos , Neoplasias do Colo/patologia , Hepatectomia , Neoplasias Hepáticas/terapia , Recidiva Local de Neoplasia/prevenção & controle , Salmonella typhimurium/patogenicidade , Animais , Neoplasias do Colo/genética , Neoplasias do Colo/metabolismo , Terapia Combinada , Proteínas de Fluorescência Verde/biossíntese , Proteínas de Fluorescência Verde/genética , Células HT29 , Humanos , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/microbiologia , Neoplasias Hepáticas/secundário , Proteínas Luminescentes/biossíntese , Proteínas Luminescentes/genética , Camundongos Nus , Salmonella typhimurium/genética , Salmonella typhimurium/crescimento & desenvolvimento , Salmonella typhimurium/metabolismo , Fatores de Tempo , Transfecção , Ensaios Antitumorais Modelo de Xenoenxerto , Proteína Vermelha Fluorescente
15.
Arch Microbiol ; 197(10): 1117-27, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26374245

RESUMO

Nitric oxide (NO) inactivates iron-sulfur enzymes in bacterial amino acid biosynthetic pathways, causing amino acid auxotrophy. We demonstrate that exogenous supplementation with branched-chain amino acids (BCAA) can restore the NO resistance of hmp mutant Salmonella Typhimurium lacking principal NO-metabolizing enzyme flavohemoglobin, and of mutants further lacking iron-sulfur enzymes dihydroxy-acid dehydratase (IlvD) and isopropylmalate isomerase (LeuCD) that are essential for BCAA biosynthesis, in an oxygen-dependent manner. BCAA supplementation did not affect the NO consumption rate of S. Typhimurium, suggesting the BCAA-promoted NO resistance independent of NO metabolism. BCAA supplementation also induced intracellular survival of ilvD and leuCD mutants at wild-type levels inside RAW 264.7 macrophages that produce constant amounts of NO regardless of varied supplemental BCAA concentrations. Our results suggest that the NO-induced BCAA auxotrophy of Salmonella, due to inactivation of iron-sulfur enzymes for BCAA biosynthesis, could be rescued by bacterial taking up exogenous BCAA available in oxic environments.


Assuntos
Aminoácidos de Cadeia Ramificada/metabolismo , Óxido Nítrico/metabolismo , Salmonella typhimurium/crescimento & desenvolvimento , Salmonella typhimurium/metabolismo , Aerobiose , Aminoácidos/metabolismo , Aminoácidos de Cadeia Ramificada/biossíntese , Animais , Proteínas de Bactérias/genética , Linhagem Celular , Hemeproteínas/genética , Hidroliases/genética , Ferro/metabolismo , Isomerases/genética , Camundongos , Salmonella typhimurium/genética , Estresse Fisiológico
16.
Oncotarget ; 6(31): 31368-77, 2015 Oct 13.
Artigo em Inglês | MEDLINE | ID: mdl-26375054

RESUMO

Liver metastasis is the most frequent cause of death from colon and other cancers. Generally, liver metastasis is recalcitrant to treatment. The aim of this study is to determine the efficacy of tumor-targeting Salmonella typhimurium A1-R on liver metastasis in orthotopic mouse models. HT-29 human colon cancer cells expressing red fluorescent protein (RFP) were used in the present study. S. typhimurium A1-R infected HT-29 cells in a time-dependent manner, inhibiting cancer-cell proliferation in vitro. S. typhimurium A1-R promoted tumor necrosis and inhibited tumor growth in a subcutaneous tumor mouse model of HT-29-RFP. In orthotopic mouse models, S. typhimurium A1-R targeted liver metastases and significantly reduced their growth. The results of this study demonstrate the future clinical potential of S. typhimurium A1-R targeting of liver metastasis.


Assuntos
Terapia Biológica , Neoplasias Colorretais/terapia , Neoplasias Hepáticas/terapia , Salmonelose Animal , Salmonella typhimurium/crescimento & desenvolvimento , Animais , Proliferação de Células , Neoplasias Colorretais/microbiologia , Neoplasias Colorretais/patologia , Citometria de Fluxo , Proteínas de Fluorescência Verde/metabolismo , Humanos , Neoplasias Hepáticas/microbiologia , Neoplasias Hepáticas/secundário , Camundongos , Camundongos Nus , Salmonella typhimurium/metabolismo , Salmonella typhimurium/patogenicidade , Células Tumorais Cultivadas , Ensaios Antitumorais Modelo de Xenoenxerto
17.
Antimicrob Agents Chemother ; 59(10): 6444-53, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26239980

RESUMO

There is increasing interest in the use of lipophilic copper (Cu)-containing complexes to combat bacterial infections. In this work, we showed that Cu complexes with bis(thiosemicarbazone) ligands [Cu(btsc)] exert antibacterial activity against a range of medically significant pathogens. Previous work using Neisseria gonorrhoeae showed that Cu(btsc) complexes may act as inhibitors of respiratory dehydrogenases in the electron transport chain. We now show that these complexes are also toxic against pathogens that lack a respiratory chain. Respiration in Escherichia coli was slightly affected by Cu(btsc) complexes, but our results indicate that, in this model bacterium, the complexes act primarily as agents that deliver toxic Cu ions efficiently into the cytoplasm. Although the chemistry of Cu(btsc) complexes may dictate their mechanism of action, their efficacy depends heavily on bacterial physiology. This is linked to the ability of the target bacterium to tolerate Cu and, additionally, the susceptibility of the respiratory chain to direct inhibition by Cu(btsc) complexes. The physiology of N. gonorrhoeae, including multidrug-resistant strains, makes it highly susceptible to damage by Cu ions and Cu(btsc) complexes, highlighting the potential of Cu(btsc) complexes (and Cu-based therapeutics) as a promising treatment against this important bacterial pathogen.


Assuntos
Antibacterianos/toxicidade , Complexos de Coordenação/toxicidade , Cobre/toxicidade , Farmacorresistência Bacteriana/efeitos dos fármacos , Tiossemicarbazonas/toxicidade , Antibacterianos/química , Transporte Biológico , Complexos de Coordenação/química , Cobre/química , Citoplasma/efeitos dos fármacos , Citoplasma/metabolismo , Transporte de Elétrons/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Escherichia coli/crescimento & desenvolvimento , Escherichia coli/metabolismo , Haemophilus influenzae/efeitos dos fármacos , Haemophilus influenzae/crescimento & desenvolvimento , Haemophilus influenzae/metabolismo , Lactobacillus acidophilus/efeitos dos fármacos , Lactobacillus acidophilus/crescimento & desenvolvimento , Lactobacillus acidophilus/metabolismo , Testes de Sensibilidade Microbiana , Viabilidade Microbiana/efeitos dos fármacos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Neisseria gonorrhoeae/efeitos dos fármacos , Neisseria gonorrhoeae/crescimento & desenvolvimento , Neisseria gonorrhoeae/metabolismo , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/crescimento & desenvolvimento , Salmonella typhimurium/metabolismo , Especificidade da Espécie , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/crescimento & desenvolvimento , Staphylococcus aureus/metabolismo , Streptococcus pneumoniae/efeitos dos fármacos , Streptococcus pneumoniae/crescimento & desenvolvimento , Streptococcus pneumoniae/metabolismo , Tiossemicarbazonas/química
18.
Pharm Biol ; 53(12): 1786-94, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25880139

RESUMO

CONTEXT: The leaves of Eriobotrya japonica (Thunb.) Lindl. (Rosaceae) are used in traditional medicine to treat inflammatory diseases. However, information about the antigenotoxic and antioxidant properties of its leaves remains to be elucidated. OBJECTIVE: The objective of this work was to evaluate the mutagenic/antimutagenic, genotoxic/antigenotoxic, and antioxidant potentials of aqueous and total oligomers flavonoid (TOF) extracts from E. japonica. MATERIALS AND METHODS: The mutagenic/antimutagenic and genotoxic/antigenotoxic potentials of extracts (50, 250, and 500 µg/plate) were evaluated, respectively, by the Ames test with 48 h incubation and the SOS chromotest test with 2 h incubation. The antioxidant capacity of these extracts (ranging from 50 to 700 µg/mL) was tested using xanthine/xanthine oxidase and the deoxyribose assays. RESULTS: Eriobotrya japonica extracts showed neither mutagenic nor genotoxic effect. The highest protective effect against methyl methanesulfonate and 2-aminoanthracene was obtained in the presence of aqueous extract, with IC50 values of 80 and 140 µg/plate, respectively, against S. typhimurium TA104. Moreover, this extract (500 µg/plate) was also able to reduce significantly the genotoxicity induced by nitrofurantoin and aflatoxin B1 with IC50 values of 140 and 240 µg/assay, respectively. Likewise, aqueous and TOF extracts inhibited xanthine oxidase and superoxide anion formation with IC50 values ranging from 45 to 95 and from 70 to 90 µg/mL, respectively. However, TOF extract is more efficient in inhibiting hydroxyl radical and chelating iron ion with IC50 values of 140 and 400 µg/mL, respectively, when compared with the aqueous extract. CONCLUSION: Eriobotrya japonica prevents the genotoxicity of some carcinogenic substances probably thanks to its antioxidant capacities.


Assuntos
Antimutagênicos/farmacologia , Antioxidantes/farmacologia , Dano ao DNA/efeitos dos fármacos , Eriobotrya , Extratos Vegetais/farmacologia , Folhas de Planta , Antimutagênicos/isolamento & purificação , Antioxidantes/isolamento & purificação , Dano ao DNA/fisiologia , Avaliação Pré-Clínica de Medicamentos/métodos , Sequestradores de Radicais Livres/metabolismo , Extratos Vegetais/isolamento & purificação , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/metabolismo
19.
Lett Appl Microbiol ; 60(4): 334-40, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25422036

RESUMO

UNLABELLED: Controlling spread of human pathogens on fresh produce is a top priority for public health reasons. Isolation of compounds from agricultural waste that would control spread of human pathogens was explored using Salmonella enterica serovar Typhimurium as a model organism. In the environment, micro-organisms migrate as a 'community' especially when they move on moist surfaces. This type of motility is characterized as swarming motility. We examined extracts from agricultural waste such as soya bean husk, peels of orange, pineapple, avocado and pomegranate for antiswarming activity. Avocado and pineapple peels showed moderate (~40%) inhibition of swarming motility while pomegranate peel extract had high antiswarming activity (~85% inhibition) and was examined in further detail. Although the pomegranate peel extract was acidic, swarm-inhibitory activity was not due to low pH and the peel extract did not inhibit growth of Salmonella. Among the key swarm motility regulatory genes, class II (fliF, fliA, fliT and fliZ) and class III (fliC and fliM) regulators were downregulated upon exposure to pomegranate peel extract. Pomegranate peels offer great potential as a bioactive repellent for pathogenic micro-organisms on moist surfaces. SIGNIFICANCE AND IMPACT OF THE STUDY: Controlling the spread of food-borne pathogens in moist environments is an important microbial food safety issue. Isolation of compounds from agricultural waste (such as fruit peels) that would control spread of human pathogens was explored using Salmonella enterica serovar Typhimurium as a model organism. Pomegranate peels offer great potential as a bioactive repellent for pathogenic micro-organisms.


Assuntos
Antibacterianos/química , Lythraceae/química , Lythraceae/microbiologia , Extratos Vegetais/química , Salmonella typhimurium/metabolismo , Ananas/química , Ananas/microbiologia , Citrus sinensis/química , Citrus sinensis/microbiologia , Flagelos/genética , Flagelos/metabolismo , Humanos , Testes de Sensibilidade Microbiana , Persea/química , Persea/microbiologia , Salmonella typhimurium/genética , Glycine max/química , Glycine max/microbiologia , Resíduos/análise
20.
Gut ; 64(2): 222-32, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24811998

RESUMO

OBJECTIVE: Antimicrobial peptides (AMP) provide protection from infection by pathogenic microorganisms and restrict bacterial growth at epithelial surfaces to maintain mucosal homeostasis. In addition, they exert a significant anti-inflammatory activity. Here we analysed the anatomical distribution and biological activity of an orally administered AMP in the context of bacterial infection and host-microbial homeostasis. DESIGN: The anatomical distribution as well as antibacterial and anti-inflammatory activity of the endogenous AMP cryptdin 2 and the synthetic peptide Pep19-2.5 at the enteric mucosal surface were analysed by immunostaining, functional viability and stimulation assays, an oral Salmonella enterica subsp. enterica sv. Typhimurium (S. Typhimurium) model and comparative microbiota analysis. RESULTS: Endogenous cryptdin 2 was found attached to bacteria of the enteric microbiota within the intestinal mucus layer. Similarly, the synthetic peptide Pep19-2.5 attached rapidly to bacterial cells, exhibited a marked affinity for the intestinal mucus layer in vivo, altered the structural organisation of endotoxin in a mucus matrix and demonstrated potent anti-inflammatory and antibacterial activity. Oral Pep19-2.5 administration induced significant changes in the composition of the enteric microbiota as determined by high-throughput 16S rDNA sequencing. This may have contributed to the only transient improvement of the clinical symptoms after oral infection with S. Typhimurium. CONCLUSIONS: Our findings demonstrate the anti-inflammatory activity and mucus affinity of the synthetic AMP Pep19-2.5 and characterise the influence on microbiota composition and enteropathogen infection after oral administration.


Assuntos
Antibacterianos/farmacocinética , Anti-Inflamatórios/farmacocinética , Mucosa Intestinal/metabolismo , Fragmentos de Peptídeos/farmacocinética , Administração Oral , Animais , Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Anti-Inflamatórios/administração & dosagem , Células Cultivadas , Defensinas , Avaliação Pré-Clínica de Medicamentos/métodos , Feminino , Interações Hospedeiro-Patógeno/fisiologia , Humanos , Mucosa Intestinal/microbiologia , Camundongos Endogâmicos C57BL , Microbiota/efeitos dos fármacos , Muco/metabolismo , Muco/microbiologia , Fragmentos de Peptídeos/administração & dosagem , Fragmentos de Peptídeos/uso terapêutico , Proteínas/metabolismo , Infecções por Salmonella/tratamento farmacológico , Infecções por Salmonella/metabolismo , Infecções por Salmonella/microbiologia , Salmonella typhimurium/efeitos dos fármacos , Salmonella typhimurium/metabolismo , Salmonella typhimurium/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA